Aurobindo Pharma USA (APUSA), a wholly owned subsidiary of Aurobindo Pharma, has completed the acquisition of Lannett Company, from Lannett Seller Holdco, following approval from the US Federal Trade Commission (FTC) on June 18, 2026.

Effective June 29, 2026, Lannett has become a wholly owned subsidiary of APUSA and will operate under the name Lannett Company LLC.

The company said the integration process has commenced with a focus on ensuring uninterrupted access to critical medicines, maintaining strong relationships with customers and business partners and supporting employees throughout the transition.

Aurobindo Pharma USA stated that the combination of the two companies' capabilities and resources is expected to strengthen the availability of essential medicines while creating long-term value for patients, healthcare customers and other stakeholders.

The acquisition marks another step in Aurobindo Pharma's strategy to expand its presence in the US pharmaceutical market by strengthening its manufacturing, product portfolio and commercial capabilities.